Suciu-Foca; Nicole
Patent Applications and Registrations
Patent applications and USPTO patent grants for Suciu-Foca; Nicole.The latest application filed is for "methods of treating cd166-expressing cancer".
- Suciu-Foca; Nicole - New York NY US
- Suciu-Foca; Nicole - Cliffside Park NJ
| Patent | Date |
|---|---|
| Methods of treating CD166-expressing cancer Grant 10,765,742 - Suciu-Foca , et al. Sep | 2020-09-08 |
| Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand Grant 10,670,603 - Suciu-Foca , et al. | 2020-06-02 |
| Methods of Treating CD166-Expressing Cancer App 20180207269 - Suciu-Foca; Nicole ; et al. | 2018-07-26 |
| ILT3 polypeptides and uses thereof Grant 9,822,161 - Suciu-Foca , et al. November 21, 2 | 2017-11-21 |
| Diagnosis and Treatment of Cancer Expressing ILT3 or ILT3 Ligand App 20170327591 - Suciu-Foca; Nicole ; et al. | 2017-11-16 |
| Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand Grant 9,696,312 - Suciu-Foca , et al. July 4, 2 | 2017-07-04 |
| ILT3 Polypeptides and Uses Thereof App 20160152682 - Suciu-Foca; Nicole ; et al. | 2016-06-02 |
| ILT3 polypeptides and uses thereof Grant 9,150,635 - Suciu-Foca , et al. October 6, 2 | 2015-10-06 |
| ILT3 polypeptides and uses thereof Grant 9,078,858 - Suciu-Foca , et al. July 14, 2 | 2015-07-14 |
| Diagnosis and Treatment of Cancer Expressing ILT3 or ILT3 Ligand App 20150110714 - Suciu-Foca; Nicole ; et al. | 2015-04-23 |
| ILT3 Polypeptides and Uses Thereof App 20130156763 - Suciu-Foca; Nicole ; et al. | 2013-06-20 |
| ILT3 Polypeptides and Uses Thereof App 20120321623 - Suciu-Foca; Nicole ; et al. | 2012-12-20 |
| ILT3 polypeptides and uses thereof Grant 8,299,016 - Suciu-Foca , et al. October 30, 2 | 2012-10-30 |
| ITL3 polypeptides and uses thereof Grant 8,207,110 - Suciu-Foca , et al. June 26, 2 | 2012-06-26 |
| ILT3 and ILT4-related compositions and methods App 20090280109 - Suciu-Foca; Nicole ; et al. | 2009-11-12 |
| Ilt3 Polypeptides And Uses Thereof App 20090274685 - SUCIU-FOCA; NICOLE ; et al. | 2009-11-05 |
| Methods of Treating Diseases by Targeting Silt3 App 20090202544 - Suciu-Foca; Nicole ; et al. | 2009-08-13 |
| Ilt3 Polypeptides and Uses Thereof App 20080311073 - Suciu-Foca; Nicole ; et al. | 2008-12-18 |
| Method of inducing anergic T helper cells Grant 7,144,728 - Suciu-Foca , et al. December 5, 2 | 2006-12-05 |
| Generation of antigen specific T suppressor cells for treatment of rejection App 20050250161 - Suciu-Foca, Nicole ; et al. | 2005-11-10 |
| Ilt3 and ilt4-related compositons and methods App 20040241167 - Suciu-Foca, Nicole ; et al. | 2004-12-02 |
| Methods for generating tolerogenic antigen presenting cells Grant 6,759,239 - Suciu-Foca , et al. July 6, 2 | 2004-07-06 |
| Generation of antigen specific T suppressor cells for treatment of rejection Grant 6,667,175 - Suciu-Foca December 23, 2 | 2003-12-23 |
| Generation of antigen specific T suppressor cells for treatment of rejection App 20030017143 - Suciu-Foca, Nicole ; et al. | 2003-01-23 |
| Method For Detecting Organ Allograft Rejection And Uses Thereof App 20020155117 - SUCIU-FOCA, NICOLE | 2002-10-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 